+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID03716089

Study Comparing Safety and Effectiveness of Laparoscopic Surgery for Gastrointestinal Stromal Tumors in Different Tumor Locations

Led by Fujian Medical University · Updated on 2025-04-08

250

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

This research aims to compare the safety and effectiveness of laparoscopic surgery for gastrointestinal stromal tumors GIST located in different parts of the stomach. Participants are divided into groups based on whether their tumor is in a favorable or unfavorable site. The study focuses on evaluating the rates of complications and mortality after surgery, as well as the 3-year disease-free survival rate. The treatment under study is laparoscopic resection of GIST performed under general anesthesia. Participants will be grouped based on tumor location into favorable or unfavorable site groups, both receiving the standard surgical therapy. The main comparison is between these two groups regarding surgical outcomes and long-term survival. The study monitors patients for at least three years after surgery. Participants will undergo laparoscopic surgery and then be closely followed for various outcomes including postoperative complications, recovery milestones like first ambulation and diet tolerance, and survival rates over three years. Researchers will collect data on tumor recurrence, surgical margins, hospital stay duration, and changes in blood markers before and after surgery. Safety and recovery are monitored for up to 30 days post-surgery, with long-term follow-up extending to 36 months.

CONDITIONS

Brief Title

Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here